PRESS RELEASES

February 25, 2021

Correction - Ventripoint Diagnostics Issues Shares in Final Payment of
Debenture Interest

February 23, 2021

Ventripoint Heart Analysis System to be used at the Stollery Children’s Hospital to Study Atrial Dysfunction in Children

February 16, 2021

Ventripoint Advances Sales, Marketing, and Distribution Partnership in the
Largest Market in World for Heart Disease: China

February 10, 2021

Ventripoint Diagnostics Issues Shares in Final Payment of Debenture
Interest

February 9, 2021

Ventripoint Diagnostics Upgrades Investor Relations Webpage

February 8, 2021

Ventripoint Issues Option Grants

January 13, 2021

Ventripoint Issues Option Grants

Ventripoint Diagnostics Reports Results of Annual General & Special
Shareholders Meeting

Ventripoint Diagnostics Reports Results of Annual General & Special
Shareholders Meeting

December 10, 2020

January 11, 2021

Ventripoint Expands to Address the Needs of Companion Animals

January 4, 2021

Kings College London Receives VMS+3.0 Ventripoint Whole Heart Analysis System

December 15, 2020

Ventripoint Diagnostics Reports Results of Annual General & Special Shareholders Meeting

December 14, 2020

Ventripoint Diagnostics Receives Loan from FedDev Regional Relief and Recovery Fund and Reminds Shareholders about Annual General Meeting Today

December 10, 2020

Ventripoint Diagnostics Receives Wage Subsidy

February 8, 2021

Correction: Ventripoint Accelerated Expiry Date of Warrants

February 3, 2021

Ventripoint Announces Complete Conversion of Secured Convertible Debentures,Exercise of Warrants and Accelerated Expiry Date of Warrants

February 5, 2021

Ventripoint Hires MarketSmart Communications to Provide Investor Relations Services

January 13, 2021

Ventripoint Announces Filing of Articles of Amendment

November 26, 2020

Ventripoint Diagnostics Issues Shares in Payment of Debenture Interest, Consulting Fees and DSU Exercise

November 26, 2020

Ventripoint Annual General Meeting

November 5, 2020

Canada's Largest Cardiac Centre Receives VMS+ 3.0 Ventripoint Whole Heart Analysis System

November 3, 2020

Ventripoint Engages Oak Hill Financial to Provide Investor Relations Services and Approval of Warrant Amendment

November 3, 2020

October 9, 2020

Ventripoint Makes Application to Amend Warrants

October 8, 2020

Ventripoint Installs Whole Heart Analysis System in MD Anderson Cancer Center

September 30, 2020

Ventripoint Announces Appointment to the Board of Directors and Option Grants

September 28, 2020

Ventripoint Remotely Installs Whole Heart Analysis in Major European Hospital

September 25, 2020

Ventripoint Engages Torrey Hill Capital to Provide Investor Relations Services

Ventripoint To Resume Trading at the Market Opening Friday, September 25, 2020

September 23, 2020

September 15, 2020

Ventripoint Provides Corporate Update and Enters Review by TSXV to Resume Trading

September 14, 2020

Ventripoint Announces Closing of Second Tranche of Non-Brokered Secured Convertible Debenture Unit Private Placement  

September 15, 2020

​​Ventripoint Diagnostics Announces U.S. FDA Clearance for VMS+ 3.0 Whole Heart Analysis System

October 17, 2019

St. Michael's Hospital to Receive VMS+ 3.0 Whole Heart Analysis System

October 16, 2019

EVENTS

2020 - VENTRIPOINT ANNUAL GENERAL MEETING

Virtual On-Line Meeting

December 14, 2020

ASE 2019 - AMERICAN SOCIETY OF ECHO

Portland, OR

June 22-25, 2019 

CSE 2019 - CANADIAN SOCIETY OF ECHO

Toronto, Ontario

April 11-13, 2019 

ACC 2019 - AMERICAN COLLEGE OF CARDIOLOGY ANNUAL CONFERENCE

 

New Orleans, LA

 

March 16-18, 2019

EUROECHO IMAGING 2018 - EUROPEAN SOCIETY OF CARDIOLOGY

Milan, Italy

December 5-8, 2018 

2 Sheppard Avenue East, Suite 605

Toronto Ontario M2N 5Y7

Canada

+1-416-848-4156

© 2021 Ventripoint Diagnostics Ltd. All Rights Reserved.

  • Twitter
  • LinkedIn
  • YouTube